HSCA Comments on FDA Draft Guidance for Drug Supply Chain Security Act (DSCSA) Standards
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to comment on the U.S. Food and Drug Administration’s (FDA’s) revised draft guidance, “DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs Guidance for Industry.”
Click here to read the full comments.
Related Posts
HSCA Applauds House Judiciary Committee for Advancing the CREATES Act
Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA)...
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA)...
Joint Letter of Support for the MEDS Act
Dear Senator Collins and Senator Smith, The undersigned organizations are...
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA)...